Nielson, Elizabeth M.

Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression

Goodwin, G. M., Aaronson, S. T., Alvarez, O., Arden, P. C., Baker, A., Bennett, J. C., Bird, C., Blom, R. E., Brennan, C., Brusch, D., et al. (2022) · New England Journal of Medicine

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 1,167

MDMA-assisted therapy for moderate to severe PTSD: A randomized, placebo-controlled phase 3 trial

Mitchell, J. M., Ot’alora G., M., van der Kolk, B., Shannon, S., Bogenschutz, M., Gelfand, Y., Paleos, C., Nicholas, C. R., Quevedo, S., Balliett, B., et al. (2023) · Nature Medicine

Psychedelics and Drug StudiesPosttraumatic Stress Disorder Research

Cited by 455

Psychedelic harm reduction and integration: A transtheoretical model for clinical practice

Gorman, I., Nielson, E. M., Molinar, A., Cassidy, K., & Sabbagh, J. (2021) · Frontiers in Psychology

Psychedelics and Drug StudiesSubstance Abuse Treatment and Outcomes

Cited by 147

Development and evaluation of a therapist training program for psilocybin therapy for treatment-resistant depression in clinical research

Tai, S. J., Nielson, E. M., Lennard-Jones, M., Johanna Ajantaival, R.-L., Winzer, R., Richards, W. A., Reinholdt, F., Richards, B. D., Gasser, P., & Malievskaia, E. (2021) · Frontiers in Psychiatry

Psychedelics and Drug StudiesPsychotherapy Techniques and Applications

Cited by 90